Thomas Rogers
Family Medicine · Kingsport, TNNPI 1891798575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Novo Nordisk at 45.3% of the total. Reporting peaked in 2021 at $1,313 and has fallen 52.5% since, to $623 in 2025.
Across 322 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AbbVie$633
- Lilly USA, LLC$534
- Merz North America, Inc.$411
- Idorsia Pharmaceuticals US Inc$322
- AstraZeneca$255
- plus $1K from 20 others
What the payments were for
- Food & beverage$6,03399%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 194 | $2,755 |
| AbbVie(2 entities) | 28 | $633 |
| Lilly USA, LLC | 33 | $534 |
| Merz North America, Inc. | 7 | $411 |
| Idorsia Pharmaceuticals US Inc | 4 | $322 |
| AstraZeneca | 10 | $255 |
| Globus Medical | 2 | $219 |
| Axsome Therapeutics, Inc. | 4 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| Galderma Laboratories, L.p. | 3 | $98 |
| Biohaven Pharmaceuticals, Inc. | 2 | $77 |
| Clarus Therapeutics Inc. | 7 | $72 |
| Corcept Therapeutics | 3 | $63 |
| Revance Therapeutics, Inc. | 2 | $61 |
| Acella Pharmaceuticals, LLC | 3 | $47 |
| Insulet Corporation | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Romark Laboratories, LC | 2 | $22 |
| Merck | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Tolmar, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,077 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $52,515 |
| MounjaroTirzepatide | 23 | $22,250 |
| EliquisApixaban | 18 | $10,184 |
| Testosterone Cypionate | 52 | $3,206 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,834 |
| SynthroidLevothyroxine Sodium | 28 | $1,789 |
| Losartan Potassium | 94 | $1,020 |
| ProgesteroneProgesterone, Micronized | 23 | $803 |
| Armour ThyroidThyroid,pork | 20 | $729 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $637 |
| Rosuvastatin Calcium | 55 | $500 |
| Minoxidil | 48 | $437 |
| ValacyclovirValacyclovir Hcl | 22 | $387 |
| Levothyroxine Sodium | 52 | $266 |
| Azithromycin | 47 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $2,755 | $52,51556 claims |
| Lilly USA, LLCMounjaro | $534 | $22,25023 claims |
| AstraZenecaSymbicort | $255 | $2,83412 claims |
| AbbVieSynthroid, Armour Thyroid | $633 | $2,51948 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Kingsport
- Curtis JantziKingsport$39K
- Warren JonesKingsport$27K
- Emily HubbsKingsport$19K
- Shelton HagerKingsport$14K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.